Johns Hopkins University School of Medicine
733 N. Broadway
Suite G49
Baltimore
Maryland
21205-2196
United States
Tel: 410-955-3182
Website: http://www.hopkinsmedicine.org/som/
Email: www@infonet.welch.jhu.edu
289 articles with Johns Hopkins University School of Medicine
-
Horizon Therapeutics plc Announces Scientific Collaboration with Leading Research Institution to Advance Research in Autoimmunity and Inflammation
11/16/2022
Horizon Therapeutics plc today announced that it has entered a multi-year scientific collaboration with Johns Hopkins University School of Medicine to identify new disease targets and develop therapies for patients with serious autoimmune and inflammatory conditions.
-
BioSpace sat down with Katy Powell, a psychiatric mental health nurse practitioner in Portland, Oregon, to discuss the relative risks and benefits associated with psychedelic-assisted therapy.
-
Aslan partners with Johns Hopkins and Duke, Editas joins forces with Immatics, Yumanity (soon to be Kineta, Inc.) teams with Janssen, Serotiny & Janssen Biotech and Ginkgo and Novo Nordisk.
-
Two researchers affiliated with Northwestern University have discovered a new drug that may outperform existing treatments for amyotrophic lateral sclerosis (ALS).
-
As the world speculates the potential impact of the novel COVID-19 variant omicron XE and subvariant BA.2, research continues to shed light on the impact and future of the pandemic.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones including T helper cells for COVID-19, new gene found that could contribute to type 1 diabetes and more.
-
Landos Biopharma Announces Research Collaboration into the NLRX1 Pathway in Multiple Sclerosis with Johns Hopkins University School of Medicine
8/26/2021
Landos Biopharma, Inc. today announced that it has entered into a research collaboration with Peter Calabresi, M.D., Director of the Multiple Sclerosis Center and Professor of Neurology at Johns Hopkins University (JHU) School of Medicine.
-
Researchers at John Hopkins made their preliminary conclusions that the vaccines produced by Pfizer-BioNTech and Moderna did not cause the hearing loss.
-
Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
4/10/2021
Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster "Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer patients" at the 112th Annual Meeting of the American Association for Cancer Research on April 10, 2021, from 8:30 AM - 11:59 PM Eastern Daylight Time.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
-
With billions of doses of COVID-19 vaccines expected to be available by year’s end, and a global population of 7.8 billion, public health officials are scrambling to deliver the vaccines in ways that are equitable and effective.
-
Highmark Health, Allegheny Health Network and Johns Hopkins Medicine Expand Collaboration
1/16/2020
Women's Gynecologic Health and Obstetrical Care, Fetal Medicine, COPD and Lung Transplantation, Among Services That Will Benefit Western Pennsylvania Patients
-
Emulate Publishes Results for Intestine-Chip Populated with Organoids; Data Demonstrates Superior Human-relevant Intestine Function than Organoids Alone
1/14/2020
Emulate’s Duodenum Intestine-Chip provides a robust system for preclinical drug assessment of drug transport, metabolism, and drug-drug interactions in the intestine
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
10/22/2019
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches [22-October-2019] NEW YORK , Oct. 22, 2019 /PRNewswire/ -- Bloomberg Philanthropies, Johns Hopkins University School of Medicine (JHUSOM), and The New York Stem Cell Foundation (NYSCF) Research Institute today
-
Drs. Lauren Averett Byers and Patrick Forde Join LUNGevity's Scientific Advisory Board
6/14/2019
LUNGevity expands its Scientific Advisory Board with two Career Development Awardees to deepen expertise in areas key to LUNGevity's research program
-
Johns Hopkins Medicine First in U.S. to Install Canon Medical’s Aquilion Precision
3/19/2019
World’s-First Ultra-High Resolution CT System Delivers Twice the Resolution of Today’s CT Systems
-
December 21 Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechani...
12/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.
-
Genovis Half-Yearly Report January – June 2018
8/28/2018
The extremely strong growth at the beginning of the year continued during the second quarter: sales surged 48 percent compared with the previous year and totaled SEK 8.6 million (5.8).